MGMT and mesothelioma: Similarly, in mesothelioma cells, high SLFN11 expression correlated with response to PARP inhibitors, and combination with temozolomide enhanced the sensitivity of cells with low MGMT expression (76), further supporting the broad potential of SLFN11 as a biomarker of DNA damage response (76).